PDL BioPharma, Inc. Revenue

Revenue of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Revenue growth rates and interactive chart. Revenue is the income generated from normal business operations and includes discounts and deductions for returned merchandise. It is the top line or gross income figure from which costs are subtracted to determine net income.


Highlights and Quick Summary

  • Revenue for the quarter ending June 29, 2020 was $5.21 Million (a -13.08% decrease compared to previous quarter)
  • Year-over-year quarterly Revenue decreased by -88.2%
  • Annual Revenue for 2019 was $54.8 Million (a -72.36% decrease from previous year)
  • Annual Revenue for 2018 was $198 Million (a -38.1% decrease from previous year)
  • Annual Revenue for 2017 was $320 Million (a 31.01% increase from previous year)
  • Twelve month Revenue ending June 29, 2020 was $51.8 Million (a -4.16% decrease compared to previous quarter)
  • Twelve month trailing Revenue decreased by -49.91% year-over-year
Trailing Revenue for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$51.8 Million $54.1 Million $54.8 Million $103 Million
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Revenue of PDL BioPharma, Inc.

Most recent Revenueof PDLI including historical data for past 10 years.

Interactive Chart of Revenue of PDL BioPharma, Inc.

PDL BioPharma, Inc. Revenue for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $5.21 $6.0
2019 $-3.56 $44.17 $7.46 $6.7 $54.76
2018 $45.12 $67.9 $46.58 $38.52 $198.11
2017 $68.04 $62.75 $143.84 $45.44 $320.06
2016 $66.49 $53.64 $21.05 $103.12 $244.3
2015 $178.06 $124.62 $138.07 $149.71 $590.45
2014 $117.08 $164.59 $162.75 $136.8 $581.23
2013 $115.72 $100.18 $148.52 $91.85 $456.26
2012 $92.4 $85.23 $125.9 $77.34 $380.88
2011 $72.81 $83.77 $122.13 $83.34 $362.04
2010 $76.13 $86.44 $120.34 $344.98

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.